InVivoMab anti-mouse IFNγ BE0055-R100mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse IFNγ
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0055-R100mg
Quantity100 mg
Applicationsin vivo IFNγ neutralization, in vitro IFNγ neutralization, ELISPOT, Flow cytometry, Western blot
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetIFN gamma
IsotypeIgG1, κ
CloneXMG1.2
Hostrat
NCBI Full Gene Nameinterferon gamma
NCBI Gene AliasesIFN-g, If2f, Ifg
ClonalityMonoclonal
ImmunogenRecombinant mouse IFNγ
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS + 0.01% Tween, pH 8.0, Contains no stabilizers or preservatives
Research AreaCytokine and Chemokine, Immunology, Innate Immunity

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Intestinal IL-17R Signaling Constrains IL-18-Driven Liver Inflammation by the Regulation of Microbiome-Derived ProductsCell reportsNovember 19, 2019Castillo-Dela Cruz P, Wanek AG, Kumar P, An X, Elsegeiny W, Horne W, Fitch A, Burr AHP, Gopalakrishna KP, Chen K, et al.RESOURCE,SOURCE,IDENTIFIER Antibodies,Antibodies,Antibodies Anti-IL-18,Genentech,N/A Anti-mouse IFNγ,BioXCell,Cat#BE0055-A025mg; RRID: AB_1107694 Anti- mouse FasL,BioLegend,Cat#93971; RRID: AB_313281 IgG Isotype Control,BioLegend,"Cat#92257,

(2) NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control MetastasisImmunityJanuary 16, 2018Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, et al.

(3) Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheCellAugust 25, 2016Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M, Klebanoff CA, Eil RL, Hickman HD, Yu Z, Pan JH, et al.

(4) The protease cathepsin L regulates Th17 cell differentiationJournal of autoimmunityDecember 1, 2015Hou L, Cooley J, Swanson R, Ong PC, Pike RN, Bogyo M, Olson ST, Remold-O'Donnell E.

(5) LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6Nature immunologySeptember 1, 2015Choi YS, Gullicksrud JA, Xing S, Zeng Z, Shan Q, Li F, Love PE, Peng W, Xue HH, Crotty S.

(6) Interleukin (IL)-21 promotes intestinal IgA response to microbiotaMucosal immunologySeptember 1, 2015Cao AT, Yao S, Gong B, Nurieva RI, Elson CO, Cong Y.

(7) PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral ImmunityCell host & microbeMay 13, 2015Zander RA, Obeng-Adjei N, Guthmiller JJ, Kulu DI, Li J, Ongoiba A, Traore B, Crompton PD, Butler NS.

(8) Control of murine cytomegalovirus infection by γδ T cellsPLoS pathogensFebruary 1, 2015Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler TH.

(9) A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signalingImmunityJanuary 20, 2015Gu AD, Zhang S, Wang Y, Xiong H, Curtis TA, Wan YY.

(10) The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cellsNature immunologyNovember 1, 2014Bertin S, Aoki-Nonaka Y, de Jong PR, Nohara LL, Xu H, Stanwood SR, Srikanth S, Lee J, To K, Abramson L, et al.

(11) Differential kinetics of antigen dependency of CD4+ and CD8+ T cellsJournal of immunology (Baltimore, Md. : 1950)April 15, 2014Rabenstein H, Behrendt AC, Ellwart JW, Naumann R, Horsch M, Beckers J, Obst R.

(12) TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanomaJournal of immunology (Baltimore, Md. : 1950)February 15, 2014Uddin MN, Zhang Y, Harton JA, MacNamara KC, Avram D.

(13) Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in miceThe Journal of clinical investigationFebruary 1, 2014Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX.

(14) CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infectionThe Journal of experimental medicineSeptember 23, 2013Kugler DG, Mittelstadt PR, Ashwell JD, Sher A, Jankovic D.

(15) Autoreactive Th1 cells activate monocytes to support regional Th17 responses in inflammatory arthritisJournal of immunology (Baltimore, Md. : 1950)April 1, 2013Simons DM, Oh S, Kropf E, Aitken M, Garcia V, Basehoar A, Caton AJ.

(16) A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunityCancer researchApril 1, 2013Yu X, Guo C, Yi H, Qian J, Fisher PB, Subjeck JR, Wang XY.

(17) IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccineProceedings of the National Academy of Sciences of the United States of AmericaOctober 5, 2010Mohr E, Cunningham AF, Toellner KM, Bobat S, Coughlan RE, Bird RA, MacLennan IC, Serre K.

(18) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsThe Journal of experimental medicineMarch 15, 2010Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, et al.

Be the First to Write a Review!

InVivoMab anti-mouse IFNγ

InVivoMab anti-mouse IFNγ

InVivoMab anti-mouse IFNγ from Bio X Cell

Description

Specifications/Features

Bio X Cell

Citations (18)

Reviews

InVivoMab anti-mouse IFNγ from Bio X Cell

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map